# KPV vs LL-37: How They Differ | PepVault

Source: https://pepvault.app/peptides/compare/kpv-vs-ll-37

Last updated: 2026-09-26

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Comparisons](https://pepvault.app/peptides/compare) KPV vs LL-37

Compared side by side

# KPV vs LL-37: how they differ

Reviewed September 2026 [How we check the library](https://pepvault.app/about#library) [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The short answer

KPV is three amino acids from the tail end of α-MSH; in cell and mouse studies it enters cells and blocks NF-κB, the master switch for inflammatory signals. LL-37 is the body’s own antimicrobial peptide: in lab studies it kills bacteria, fungi and some viruses and steers immune responses, and it can be anti- or pro-inflammatory depending on context. No human study has tested KPV, and LL-37 has been tested as a drug only as a topical treatment for leg and foot ulcers.

## Side by side

| Compared | [KPV](https://pepvault.app/peptides/kpv) | [LL-37](https://pepvault.app/peptides/ll-37) |
| --- | --- | --- |
| Category | Healing & recovery | Healing & recovery |
| Also known as | Lys-Pro-Val, α-MSH tripeptide | Cathelicidin, hCAP-18, CAP-18 |
| What it is | One of the smallest bioactive peptides: three amino acids from the tail end of α-MSH. | Your body's own antimicrobial peptide. |
| How it works | C-terminal tripeptide of α-MSH. A potent anti-inflammatory in cell and mouse studies that works mainly inside cells rather than through melanocortin receptors: it enters through the PepT1 transporter and blocks NF-κB signaling. In mice it eased colitis and damped allergic skin reactions; as eye drops it sped corneal wound healing in rabbits; in lab dishes it slowed Staphylococcus aureus and Candida albicans. | Human antimicrobial peptide with broad-spectrum antimicrobial activity. In lab and animal studies it modulates innate immunity, breaks up biofilms and promotes wound healing; it can be anti- or pro-inflammatory depending on context. |
| Commonly reported | A calmer gut and calmer skin. No human study has tested it yet. | Noticeable injection-site redness or itching, and for some a flu-like, achy feeling in the first days. As a drug it has only been tested as a topical treatment for leg and foot ulcers, with mixed results; injected LL-37 hasn't been studied in people. |
| Studied range | Research range: 100–300 mcg. Studied in research — not a recommendation. | Research range: 100–300 mcg. Studied in research — not a recommendation. |
| How often | Daily | Daily or EOD |
| Half-life | Not measured: no half-life for KPV has been published, in people or animals | Unknown in humans (short; broken down by proteases) |
| Route | SubQ injection, Oral | SubQ injection |
| Typical run | 4–8 weeks typical for gut protocols. Can reassess after each cycle. | Short cycles of 2–4 weeks due to limited data. Conservative approach advised. |
| Evidence | Emerging: primarily preclinical / limited human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Injection site irritation, mild nausea | Injection site pain, redness, mild systemic inflammation |

Typical run: Community practice — opinions vary. Not a clinical recommendation.

<!--promo-->

PepVault for iPhone

## Taking KPV or LL-37? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

### KPV

- Day 1–7 Week one: your starting point
- Day 7–21 Users often report a calmer gut
- Day 21–42 Some report calmer skin
- Day 42–56 Weeks 6 to 8: taking stock

[Every card for KPV, with its sources](https://pepvault.app/peptides/kpv#weeks)

### LL-37

- Day 1–7 Some feel a flu-like wave early
- Day 7–21 Weeks 1 to 3: check what changed
- Day 21–28 Cycle wrap-up — time to assess

[Every card for LL-37, with its sources](https://pepvault.app/peptides/ll-37#weeks)

## Together or one or the other

KPV and LL-37 are a common stack: each lists the other among its common stacks.

Community · LL-37

### An immune-support trio

Three immune layers at once: LL-37 works on microbes directly, KPV calms inflammation, and thymosin alpha-1 tunes the adaptive side. Commonly stacked for immune support; users judge it by how they feel over several weeks.

## With this comparison

### KPV

- [KPV: the full reference](https://pepvault.app/peptides/kpv)
- [KPV dose guide](https://pepvault.app/lab/dosage/kpv)

### LL-37

- [LL-37: the full reference](https://pepvault.app/peptides/ll-37)
- [LL-37 dose guide](https://pepvault.app/lab/dosage/ll-37)

### Mixing charts

- [KPV 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/kpv-5mg)
- [LL-37 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/ll-37-5mg)

### Studies

- [KPV in drinking water reduced colitis in 2 mouse models](https://pepvault.app/research/kpv-dalmasso-2008)
- [KPV reduced white blood cell buildup in mice with peritonitis](https://pepvault.app/research/kpv-getting-2003)
- [All 2 studies](https://pepvault.app/research#kpv)
- [LL-37 cream: bigger granulation gains in diabetic foot ulcers](https://pepvault.app/research/ll-37-miranda-2023)
- [LL-37: no healing gain over placebo for venous leg ulcers overall](https://pepvault.app/research/ll-37-heal-ll-37-2021)
- [LL-37 drove IL-1β and IL-18 release from human and murine macrophages](https://pepvault.app/research/ll-37-kahlenberg-2013)
- [All 4 studies](https://pepvault.app/research#ll-37)

### Compared with

- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [TB-500 vs KPV](https://pepvault.app/peptides/compare/tb-500-vs-kpv)
- [GHK-Cu vs KPV](https://pepvault.app/peptides/compare/ghk-cu-vs-kpv)
- [Thymosin Alpha-1 vs LL-37](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-ll-37)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Cycle](https://pepvault.app/glossary/cycle)
- [Stack](https://pepvault.app/glossary/stack)

## Questions people ask

### How long do KPV and LL-37 last?

The half-life of KPV is not measured: no half-life for KPV has been published, in people or animals. The half-life of LL-37 is unknown in humans (short; broken down by proteases).

### How often are KPV and LL-37 taken?

KPV: daily. Routes: SubQ injection, oral. LL-37: daily or EOD. Route: SubQ injection.

### How are KPV and LL-37 dosed in research?

The research range for KPV is 100–300 mcg. The research range for LL-37 is 100–300 mcg. Studied in research — not a recommendation.

### What are the common side effects of KPV and LL-37?

For KPV, the library lists: injection site irritation, mild nausea. For LL-37: injection site pain, redness, mild systemic inflammation.

### Are KPV and LL-37 taken together?

KPV and LL-37 are a common stack: each lists the other among its common stacks. Three immune layers at once: LL-37 works on microbes directly, KPV calms inflammation, and thymosin alpha-1 tunes the adaptive side. Commonly stacked for immune support; users judge it by how they feel over several weeks.

## Each one in full

- [KPV: dosage, half-life & reference guide](https://pepvault.app/peptides/kpv)
- [LL-37: dosage, half-life & reference guide](https://pepvault.app/peptides/ll-37)
- [KPV dose guide](https://pepvault.app/lab/dosage/kpv)
- [LL-37 dose guide](https://pepvault.app/lab/dosage/ll-37)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking KPV or LL-37? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking KPV or LL-37? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this comparison

### KPV

- [KPV: the full reference](https://pepvault.app/peptides/kpv)
- [KPV dose guide](https://pepvault.app/lab/dosage/kpv)

### LL-37

- [LL-37: the full reference](https://pepvault.app/peptides/ll-37)
- [LL-37 dose guide](https://pepvault.app/lab/dosage/ll-37)

### Mixing charts

- [KPV 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/kpv-5mg)
- [LL-37 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/ll-37-5mg)

### Studies

- [KPV in drinking water reduced colitis in 2 mouse models](https://pepvault.app/research/kpv-dalmasso-2008)
- [KPV reduced white blood cell buildup in mice with peritonitis](https://pepvault.app/research/kpv-getting-2003)
- [All 2 studies](https://pepvault.app/research#kpv)
- [LL-37 cream: bigger granulation gains in diabetic foot ulcers](https://pepvault.app/research/ll-37-miranda-2023)
- [LL-37: no healing gain over placebo for venous leg ulcers overall](https://pepvault.app/research/ll-37-heal-ll-37-2021)
- [LL-37 drove IL-1β and IL-18 release from human and murine macrophages](https://pepvault.app/research/ll-37-kahlenberg-2013)
- [All 4 studies](https://pepvault.app/research#ll-37)

### Compared with

- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [TB-500 vs KPV](https://pepvault.app/peptides/compare/tb-500-vs-kpv)
- [GHK-Cu vs KPV](https://pepvault.app/peptides/compare/ghk-cu-vs-kpv)
- [Thymosin Alpha-1 vs LL-37](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-ll-37)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Cycle](https://pepvault.app/glossary/cycle)
- [Stack](https://pepvault.app/glossary/stack)

<!--promo-->

PepVault for iPhone

## Taking KPV or LL-37? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## More comparisons

- [All peptide comparisons](https://pepvault.app/peptides/compare)
- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [Thymosin Alpha-1 vs LL-37](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-ll-37)
- [TB-500 vs KPV](https://pepvault.app/peptides/compare/tb-500-vs-kpv)
- [GHK-Cu vs KPV](https://pepvault.app/peptides/compare/ghk-cu-vs-kpv)
- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Healing & recovery peptides](https://pepvault.app/peptides#healing)

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
